News
-
-
PRESS RELEASE
HAMBORNER REIT AG: Stable business performance in the first half of the year in line with planning - confirmation of full-year forecast for 2024
HAMBORNER REIT AG reports stable business performance in the first half of 2024, with increased rental income and FFO. Full-year forecast for 2024 confirmed -
-
-
PRESS RELEASE
Communiqué : Le traitement d’induction par Sarclisa a démontré une amélioration significative de la survie sans progression chez les patients atteints d’un myélome multiple nouvellement diagnostiqué et éligibles à une transplantation
Le traitement d’induction par Sarclisa montre une amélioration significative de la survie sans progression chez les patients atteints de myélome multiple nouvellement diagnostiqués et éligibles à une transplantation -
PRESS RELEASE
Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
New data shows Sarclisa induction therapy improves progression-free survival in transplant-eligible newly diagnosed multiple myeloma patients. GMMG-HD7 study results are promising for Sarclisa as part of frontline treatment -
PRESS RELEASE
grenke increases Group earnings and improves cost-income ratio in the first half of 2024
grenke AG increases Group earnings by 11.3% and improves cost-income ratio to 57.1% in the first half of 2024. The company reconfirms its 2024 forecast, showcases refinancing strength, and reports positive financial figures -
-
PRESS RELEASE
Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Maintains Profitable Growth
Knorr-Bremse AG maintains profitable growth with impressive 2024 first half results and increased full-year guidance. Continuity on the Executive Board confirmed. Details on BOOST 2026 strategy and divisional performances -
PRESS RELEASE
Allianz SE: Allianz achieves record profits in first half 2024
Allianz SE achieves record profits in the first half of 2024, driven by strong performance in all business segments. Operating profit reaches 7.9 billion euros, with core net income of 5.0 billion euros. Solvency II ratio at 206 percent
